Regenerative Medicine Market Size, Share, Growth & Industry Analysis, By Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecules and Biologics), By Application (Musculoskeletal Disorders, Oncology, Dermatology, Cardiovascular, Neurology, Others), By End-User (Hospitals and Clinics, Research Institutes, Academic Institutes, Specialty Centers), and Regional Analysis, 2024-2031

1 INTRODUCTION OF THE GLOBAL REGENERATIVE MEDICINE MARKET
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Limitations
1.5 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 Data Collection
3.1.1 Secondary Sources
3.1.2 Primary Sources
3.1.3 Research Flow
3.2 Subject Matter Expert Advice
3.3 Quality Check
3.4 Final Review
3.5 Bottom-Up Approach
3.6 Top-down Approach

4 GLOBAL REGENERATIVE MEDICINE MARKET OUTLOOK
4.1 Market Evolution
4.2 Overview
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.3.4 Challenges
4.4 Pricing Analysis
4.5 Porter’s Five Forces Analysis
4.6 Value Chain Analysis
4.7 Macroeconomic Analysis

5 IMPACT OF RUSSIA-UKRAINE WAR

6 GLOBAL REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE
6.1 Overview
6.2 Cell Therapy
6.3 Gene Therapy
6.4 Tissue Engineering
6.5 Small Molecules and Biologics

7 GLOBAL REGENERATIVE MEDICINE MARKET, BY APPLICATION
7.1 Overview
7.2 Musculoskeletal Disorders
7.3 Oncology
7.4 Dermatology
7.5 Cardiovascular
7.6 Neurology
7.7 Others

8 GLOBAL REGENERATIVE MEDICINE MARKET, BY END-USER
8.1 Overview
8.2 Hospitals and Clinics
8.3 Research Institutes
8.4 Academic Institutes
8.5 Specialty Centers

9 GLOBAL REGENERATIVE MEDICINE MARKET, BY GEOGRAPHY
9.1 Overview

10 NORTH AMERICA
10.1 U.S.
10.2 Canada
10.3 Mexico

11 EUROPE
11.1 Germany
11.2 UK
11.3 France
11.4 Italy
11.5 Spain
11.6 Russia
11.7 Rest of Europe

12 ASIA-PACIFIC
12.1 China
12.2 Japan
12.3 India
12.4 South Korea
12.5 Rest of Asia-Pacific

13 MIDDLE EAST & AFRICA
13.1 GCC
13.2 South Africa
13.3 North Africa
13.4 Rest of Middle East & Africa

14 LATIN AMERICA
14.1 Brazil
14.2 Argentina
14.3 Rest of South America

15 GLOBAL REGENERATIVE MEDICINE MARKET COMPETITIVE LANDSCAPE
15.1 Overview
15.2 Key Developments
15.3 Key Strategic Developments
15.4 Company Market Ranking
15.5 Regional Footprint
15.6 Industry Footprint

16 COMPANY PROFILES
16.1 Organogenesis Holdings Inc.
16.1.1 Key Facts
16.1.2 Financial Overview
16.1.3 Product Benchmarking
16.1.4 Recent Developments
16.1.5 Winning Imperatives
16.1.6 Current Focus & Strategies
16.1.7 Threat from competition
16.1.8 SWOT Analysis
16.2 Novartis AG
16.2.1 Key Facts
16.2.2 Financial Overview
16.2.3 Product Benchmarking
16.2.4 Recent Developments
16.2.5 Winning Imperatives
16.2.6 Current Focus & Strategies
16.2.7 Threat from competition
16.2.8 SWOT Analysis
16.3 Vericel Corporation
16.3.1 Key Facts
16.3.2 Financial Overview
16.3.3 Product Benchmarking
16.3.4 Recent Developments
16.3.5 Winning Imperatives
16.3.6 Current Focus & Strategies
16.3.7 Threat from competition
16.3.8 SWOT Analysis
16.4 Smith & Nephew PLC
16.4.1 Key Facts
16.4.2 Financial Overview
16.4.3 Product Benchmarking
16.4.4 Recent Developments
16.4.5 Winning Imperatives
16.4.6 Current Focus & Strategies
16.4.7 Threat from competition
16.4.8 SWOT Analysis
16.5 Integra LifeSciences Holdings Corporation
16.5.1 Key Facts
16.5.2 Financial Overview
16.5.3 Product Benchmarking
16.5.4 Recent Developments
16.5.5 Winning Imperatives
16.5.6 Current Focus & Strategies
16.5.7 Threat from competition
16.5.8 SWOT Analysis
16.6 Astellas Pharma Inc.
16.6.1 Key Facts
16.6.2 Financial Overview
16.6.3 Product Benchmarking
16.6.4 Recent Developments
16.7 Takeda Pharmaceutical Company Limited
16.7.1 Key Facts
16.7.2 Financial Overview
16.7.3 Product Benchmarking
16.7.4 Recent Developments
16.8 Medipost Co., Ltd.
16.8.1 Key Facts
16.8.2 Financial Overview
16.8.3 Product Benchmarking
16.8.4 Recent Developments
16.9 MiMedx Group, Inc.
16.9.1 Key Facts
16.9.2 Financial Overview
16.9.3 Product Benchmarking
16.9.4 Recent Developments
16.10 Thermo Fisher Scientific Inc
16.10.1 Key Facts
16.10.2 Financial Overview
16.10.3 Product Benchmarking
16.10.4 Recent Developments

LIST OF TABLES

TABLE 1 Global Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 2 Global Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 3 Global Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 4 Global Regenerative Medicine Market Revenue, By Geography, 2021 – 2031 (USD Billion)
TABLE 5 North America Regenerative Medicine Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 6 North America Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 7 North America Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 8 North America Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 9 US Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 10 US Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 11 US Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 12 Canada Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 13 Canada Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 14 Canada Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 15 Mexico Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 16 Mexico Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 17 Mexico Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 18 Europe Regenerative Medicine Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 19 Europe Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 20 Europe Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 21 Europe Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 22 Germany Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 23 Germany Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 24 Germany Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 25 France Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 26 France Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 27 France Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 28 UK Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 29 UK Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 30 UK Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 31 Spain Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 32 Spain Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 33 Spain Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 34 Italy Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 35 Italy Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 36 Italy Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 37 Russia Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 38 Russia Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 39 Russia Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 40 Rest of Europe Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 41 Rest of Europe Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 42 Rest of Europe Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 43 Asia-Pacific Regenerative Medicine Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 44 Asia-Pacific Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 45 Asia-Pacific Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 46 Asia-Pacific Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 47 China Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 48 China Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 49 China Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 50 Japan Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 51 Japan Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 52 Japan Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 53 India Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 54 India Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 55 India Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 56 South Korea Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 57 South Korea Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 58 South Korea Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 59 Rest of Asia-Pacific Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 60 Rest of Asia-Pacific Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 61 Rest of Asia-Pacific Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 62 Middle East and Africa Regenerative Medicine Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 63 Middle East and Africa Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 64 Middle East and Africa Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 65 Middle East and Africa Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 66 GCC Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 67 GCC Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 68 GCC Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 69 North Africa Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 70 North Africa Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 71 North Africa Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 72 South Africa Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 73 South Africa Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 74 South Africa Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 75 Rest of Middle East & Africa Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 76 Rest of Middle East & Africa Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 77 Rest of Middle East & Africa Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 78 Latin America Regenerative Medicine Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 79 Latin America Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 80 Latin America Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 81 Latin America Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 82 Brazil Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 83 Brazil Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 84 Brazil Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 85 Argentina Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 86 Argentina Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 87 Argentina Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 88 Rest of Latin America Regenerative Medicine Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 89 Rest of Latin America Regenerative Medicine Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 90 Rest of Latin America Regenerative Medicine Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 91 Company Market Ranking
TABLE 92 Regional Footprint
TABLE 93 Product Benchmarking
TABLE 94 Recent Developments
TABLE 95 Winning Imperatives

LIST OF FIGURES

FIG. 1 Market Segmentation
FIG. 2 Research Timeline
FIG. 3 Global Regenerative Medicine Market 2021-2031 (USD Billion)
FIG. 4 Global Regenerative Medicine Market Geographical Analysis (CAGR %)
FIG. 5 Global Regenerative Medicine Absolute Market Opportunity (USD Billion)
FIG. 6 Global Regenerative Medicine Market Attractiveness (USD Billion)
FIG. 7 Global Regenerative Medicine Market, By Deployment Mode, 2021-2031 (USD Billion)
FIG. 8 Global Regenerative Medicine Market, By Application, 2021-2031 (USD Billion)
FIG. 9 Global Regenerative Medicine Market, By End-User, 2021-2031 (USD Billion)
FIG. 11 Research Methodology
FIG. 12 Research Process
FIG. 13 Bottom-Up Approach
FIG. 14 Top-Bottom Approach
FIG. 15 Market Dynamics Overview
FIG. 16 Porter's Five Forces Analysis
FIG. 17 Value Chain Analysis
FIG. 18 Macroeconomic Analysis
FIG. 19 Global Regenerative Medicine Market Revenue Share, By Deployment Mode, 2021 and 2031 (%)
FIG. 20 Global Regenerative Medicine Market Revenue Share, By Application, 2021 and 2031 (%)
FIG. 21 Global Regenerative Medicine Market Revenue Share, By End-User, 2021 and 2031 (%)
FIG. 22 Global Regenerative Medicine Market Revenue Share, By Geographic Regions, 2021 and 2031 (%)
FIG. 23 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 24 North America Regenerative Medicine Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 25 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 26 Europe Regenerative Medicine Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 27 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 28 Asia-Pacific Regenerative Medicine Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 29 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 30 Middle East & Africa Regenerative Medicine Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 31 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 32 Latin America Regenerative Medicine Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 33 Key Strategic Development
FIG. 34 Key Facts
FIG. 35 Financial Overview
FIG. 36 SWOT Analysis